CO:LAB Business  Intelligent Retinal Imaging Systems, Inc. (IRIS), the industry leader in early detection systems for diabetic eye disease, today announced the company successfully closed a round of Series B financing. The round was led by Ballast Point Ventures, a later-stage venture capital and growth equity firm that invests in rapidly growing, privately owned companies in the health care and technology industries. The round also includes investments from two healthcare system funds, Providence Ventures and current IRIS customer, CoxHealth. Funds raised will be used to support the company’s expansion and growth strategy as well as to support IRIS’s goal of developing the next generation of products that detect eye disease and improve the monitoring and care of patients in diabetic populations. Read Full Release

CO:LAB, a program of FloridaWest EDA, supported by Pensacola State College, is Pensacola's business incubator and growth accelerator.  Find out more

"FloridaWest is committed to our CO:LAB businesses and the promotion of a dynamic work environment that allows them to grow," said Scott Luth, FloridaWest CEO, " IRIS is a great example of Pensacola’s entrepreneurial spirit that is creating new jobs and new business for Escambia County and Greater Pensacola."